ICYMI: Antimicrobial resistance spotlighted as growing public health threat

On June 28, PhRMA Chief Operating Officer Lori Reilly joined Executive Director of CARB-X, Kevin Outterson, Esq., and Interim Secretariat Lead of the Global Antimicrobial Resistance (AMR) R&D Hub, Dr. Ralf Sudbark in a discussion about the changes that are needed to combat the threat of AMR. The conversation occurred atForeign Policy ’sGlobal Health Forum.
Source: The Catalyst - Category: Pharmaceuticals Tags: Coronavirus Antimicrobial Resistance Source Type: news